How Cronos Group Is Growing Its Core Medical Marijuana Business

📆 28/09/2018 04:21 ص
📰 Forbes

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 53%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

Cronos Group has seen its stock price rise by over 70% over the last six months. While the rally has largely been driven by legalization in Canada and deal-making activity in the industry, Cronos’ bread-and-butter medical marijuana business is likely to remain a crucial driver for the company.

اكتب تعليق

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Altria in talks to buy cannabis company Cronos GroupMarlboro cigarette maker Altria is in early talks to acquire Canadian cannabis producer Cronos, as it seeks to diversify its business beyond traditional smokers, a person familiar with the matter told CNBC. 😳🙄 Uwu uwu...cokiegig88 it doesn't take much to get these guys going...
مصدر: CNBC - 🏆 12. / 72 اقرأ أكثر »

Marlboro maker Altria is talking with pot producer Cronos about investmentMarlboro cigarette maker Altria Group Inc. is discussing an investment in marijuana producer Cronos Group Inc., as legacy companies continue to look for ways into the marijuana industry.
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »

Altria to invest $1.8 billion in cannabis company Cronos GroupAltria Group said Friday it agreed to buy a 45 percent stake in leading cannabinoid company Cronos Group for about $1.8 billion. That was the complete value of the company, as of yesterdays close. IMO Altria will own the company outright in a few years, with no more capital outlay. Bad idea legalizing dope. Drug dealers are now legal.
مصدر: CNBC - 🏆 12. / 72 اقرأ أكثر »